For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

Patients achieved an estimated weight loss of 9.7% on ... after 36 weeks or whether the trends suggest further improvements are possible in longer trials. In a study of Eli Lilly’s Zepbound ...

A Lilly-sponsored trial showed last month that Zepbound helped patients lose an average of 20.2% of their weight after 72 weeks, compared to 13.7% for a group treated with Wegovy. In December ...

Looking for weight loss options? GLP-1 agonist medications, originally designed to manage type 2 diabetes, are now FDA-approved for weight management. Klarity connects you with healthcare ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide ... a 20.2% reduction in weight at 72 weeks, compared to 13.7% with the maximum tolerated ...

Haley Sipes lost 75 pounds over 10 months with diet and exercise alone. On TikTok, where the 31-year-old mother of three chronicled her weight loss journey, commenters speculated that she was using ...

In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative ... their brand names Ozempic and Zepbound, researchers have ...

Zepbound (tirzepatide) is only available on prescription for people with obesity, or those with overweight. Learn how to get Zepbound online, in-person, and through the drug’s manufacturer, Eli ...

Shares of fellow Danish obesity drug maker Zealand Pharma also tracked higher, last up 4.7%, while Zepbound-maker ... showed average weight loss of 13.1% after 12 weeks. The company said at ...

Weaker than expected data from the trial was a blow to Novo's ambitions to find a more powerful competitor to Lilly's Zepbound ... overall weight loss of 22.7% after 68 weeks, with 40.4% losing ...

(CNN) — For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead ...